Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « checkpoint »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
cheaper < checkpoint < checkpoints  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000027 (2020) Shanshan Deng [États-Unis, République populaire de Chine] ; Michael J. Clowers [États-Unis] ; Walter V. Velasco [États-Unis] ; Marco Ramos-Castaneda [États-Unis] ; Seyed Javad Moghaddam [États-Unis]Understanding the Complexity of the Tumor Microenvironment in K-ras Mutant Lung Cancer: Finding an Alternative Path to Prevention and Treatment
000065 (2020) Ian Pirker [Suisse] ; Andrea Rubbert-Roth [Suisse] ; Johannes Von Kempis [Suisse] ; Martin Fehr [Suisse] ; Thomas Neumann [Suisse]Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy.
000141 (2020) Adam Amlani [Canada] ; Claire Barber [Canada] ; Aurore Fifi-Mah [Canada] ; Jose Monzon [Canada]Successful Treatment of Cytokine Release Syndrome with IL-6 Blockade in a Patient Transitioning from Immune-Checkpoint to MEK/BRAF Inhibition: A Case Report and Review of Literature.
000183 (2020) Ibai Los-Arcos [Espagne] ; Juan Aguilar-Company [Espagne] ; Isabel Ruiz-Camps [Espagne]Risk of infection associated with new therapies for lymphoproliferative syndromes.
000208 (2020) Natalia Maximova [Italie] ; Alessandra Maestro [Italie] ; Davide Zanon [Italie] ; Annalisa Marcuzzi [Italie]Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration
000240 (2020) James Kalmuk [États-Unis] ; Jon Puchalla [États-Unis] ; Gong Feng [États-Unis] ; Anshu Giri [États-Unis] ; John Kaczmar [États-Unis]Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge
000265 (2020) G. S. Braun [Allemagne] ; M. Kirschner [Allemagne] ; A. Rübben [Allemagne] ; R. U. Wahl [Allemagne] ; K. Amann [Allemagne] ; K. Benesova [Allemagne] ; J. Leipe [Allemagne]Nebenwirkungen neuer onkologischer Immuntherapien
000268 (2020) Muhammad Khan [République populaire de Chine] ; Sumbal Arooj [Pakistan] ; Hua Wang [République populaire de Chine]NK Cell-Based Immune Checkpoint Inhibition
000288 (2020) Xiaoyan Si ; Peng Song ; Jun Ni ; Mingyi Di ; Chunxia He ; Li Zhang ; Xiaowei Liu ; Yue Li ; Hanping Wang ; Xiaoxiao Guo ; Jiaxin Zhou ; Lian Duan ; Xu Yang ; Mengzhao Wang ; Li ZhangManagement of immune checkpoint inhibitor‐related adverse events: A review of case reports
000345 (2020) Immune-Related Adverse Events: Pneumonitis
000462 (2020) Renate U. Wahl ; Marike Leijs [Belgique] ; Arturo Araujo [Royaume-Uni] ; Albert RübbenCorrelative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma—An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy of Cancer
000499 (2020) Junling Zhuang ; Jianhua Du ; Xiaoxiao Guo ; Jiaxin Zhou ; Lian Duan ; Wei Qiu ; Xiaoyan Si ; Li Zhang ; Yue Li ; Xiaowei Liu ; Hanping Wang ; Daobin Zhou ; Li ZhangClinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events
000558 (2020) Jerry B. Harvey [États-Unis] ; Luan H. Phan [États-Unis] ; Oscar E. Villarreal [États-Unis] ; Jessica L. Bowser [États-Unis]CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
000563 (2020) Parth Shah ; Vinay Sundaram ; Einar BjörnssonBiologic and Checkpoint Inhibitor‐Induced Liver Injury: A Systematic Literature Review
000636 (????) Melissa Bersanelli [Italie]Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "checkpoint" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "checkpoint" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    checkpoint
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021